Michael’s 35-year involvement in cancer research was initiated from his clinical experience as a colorectal surgeon. He has published numerous articles in international journals that cover aspects of epidemiology, screening, molecular biology and biochemistry. Prior to his full time appointment as CEO/CSO of InterK, and in addition to his clinical and academic roles, Michael was actively involved in healthcare administration and management.
Michael’s focus on cancer research led to the formation of InterK in 2002.
Stephen has been involved with all aspects of new product development and commercialization in the biotechnology sector for more than 25 years. Prior to his involvement with InterK (as co-founder) Stephen patented and subsequently successfully commercialized a range of surgical devices.